Form 8-K - Current report:
SEC Accession No. 0001539497-21-000797
Filing Date
2021-06-07
Accepted
2021-06-07 15:31:13
Documents
2
Period of Report
2021-05-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K n2583_x1-8k.htm 8-K 65877
2 FORM OF CONVERTIBLE NOTE AGREEMENT DATED MAY 2 AND 3, 2021 exhibit10-58.htm EX-10.58 62806
  Complete submission text file 0001539497-21-000797.txt   130221
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 21999347
SIC: 2834 Pharmaceutical Preparations